Koreg 12.5 mg (Tablet)

Unit Price: ৳ 5.02 (3 x 10: ৳ 150.60)
Strip Price: ৳ 50.20

Medicine Details

Indications

  • Treatment of mild heart failure
  • Treatment of moderate heart failure
  • Treatment of severe heart failure
  • Treatment of ischemic heart failure
  • Treatment of cardiomyopathic heart failure
  • Reduction of disease progression
  • Cardiovascular death prevention
  • Cardiovascular hospitalization prevention
  • Medication adjustment
  • Patients intolerance to ACE inhibitor
  • Patients not receiving digitalis therapy
  • Patients not receiving hydralazine therapy
  • Patients not receiving nitrate therapy

Pharmacology

  • Non-selective antagonism of β-adrenergic receptors
  • a-adrenergic antagonistic activity
  • Antiproliferative properties
  • Scavenger of reactive free oxidant radicals
  • Treatment of hypertension
  • Treatment of angina pectoris
  • Treatment of congestive heart failure

Dosage & Administration

  • Initial dosage in hypertension - 12.5 mg once daily
  • Usual dosage in hypertension - 25 mg once daily
  • Maximum dosage in hypertension - 50 mg daily
  • Initial dosage in angina pectoris - 12.5 mg twice daily
  • Recommended dosage in angina pectoris - 25 mg twice daily
  • Maximum dosage in angina pectoris - 50 mg daily
  • Initial dosage in heart failure - 3.125 mg twice daily
  • Maximum dosage in heart failure - 25 mg twice daily (in patients less than 85 kg body-weight) to 50 mg twice daily (in patients over 85 kg)

Interaction

  • Interaction with Digoxin
  • Interaction with Rifampin
  • Interaction with Warfarin
  • Interaction with Clonidine
  • Increased monitoring of digoxin recommended
  • 60% decrease in Cmax and AUC with Rifampin pretreatment
  • No alteration of in vitro plasma protein binding of warfarin with Koreg
  • Potentiation of pressor reaction with clonidine withdrawal

Contraindications

  • Decompensated heart failure requiring intravenous inotropic therapy
  • Bronchial asthma
  • Related bronchospastic conditions
  • Second or third-degree AV block
  • Sick sinus syndrome
  • Cardiogenic shock
  • Severe bradycardia

Side Effects

  • Postural hypotension
  • Dizziness
  • Headache
  • Fatigue
  • Gastro-intestinal disturbances
  • Bradycardia
  • Diminished peripheral circulation
  • Peripheral oedema
  • Painful extremities
  • Dry mouth
  • Dry eyes
  • Eye irritation
  • Disturbed vision
  • Impotence
  • Disturbances of micturition
  • Influenza-like symptoms
  • Angina
  • AV block
  • Exacerbation of intermittent claudication
  • Exacerbation of Raynaud's phenomenon
  • Allergic skin reactions
  • Exacerbation of psoriasis
  • Nasal stuffiness
  • Wheezing
  • Depressed mood
  • Sleep disturbances
  • Paresthesia
  • Changes in liver enzymes
  • Thrombocytopenia
  • Leukopenia

Pregnancy & Lactation

  • Not to be used during breast-feeding
  • No studies performed in lactating women
  • Excretion in breast milk shown in animal studies
  • Safety and efficacy not established in children
  • Not to be used during pregnancy
  • Crosses the placental barrier

Precautions & Warnings

  • Caution in hepatic impairment
  • Clinical status monitoring after initiation
  • Heart failure monitoring after increasing each dose
  • Renal function monitoring before increasing dose

Therapeutic Class

  • Alpha adrenoceptor blocking drugs
  • Beta-adrenoceptor blocking drugs
  • Beta-blockers

Storage Conditions

  • Keep below 30°C temperature
  • Away from light & moisture
  • Keep out of the reach of children

Related Brands